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SUMMARY 
 
 The NAD(P)H:flavin oxidoreductase from Escherichia coli, named Fre, is 
a monomer of 26.2 kDa that catalyzes the reduction of free flavins using 
NADPH or NADH as electron donor. The enzyme does not contain any 
prosthetic group but accommodates  both the reduced pyridine nucleotide and 
the flavin in a ternary complex prior to oxidoreduction. The specificity of the 
flavin reductase for the pyridine nucleotide was studied by steady-state kinetics 
using a variety of NADP analogs. Both the nicotinamide ring and the adenosine 
part of the substrate molecule have been found to be important for binding to the 
polypeptide chain. However, in the case of NADPH, the 2’-phosphate  group 
destabilized almost completely the interaction with the adenosine moiety. 
Moreover, NADPH and NMNH are very good substrates for the flavin reductase 
and we have shown that both these molecules bind to the enzyme almost 
exclusively by the nicotinamide ring. This provides evidence that the flavin 
reductase exhibits a unique mode for recognition of the reduced pyridine 
nucleotide. In addition, we have shown that the flavin reductase selectively 
transfers the pro-R hydrogen from the C-4 position of the nicotinamide ring and 
is therefore classified as an A side specific enzyme.  
INTRODUCTION 
 
 Flavin reductases are enzymes defined by their ability to catalyze the 
reduction of free flavins (riboflavin, FMN or FAD) by using reduced pyridine 
nucleotides, NADPH or NADH (1). The products of these enzyme activities, 
protein-free reduced flavins, were suggested to have important biological 
functions as electron transfer mediators, even though the real physiological 
significance of these mediators has so far not been fully appreciated. In fact, in 
vitro, free reduced flavins can reduce ferric complexes or iron proteins very 
efficiently and it has been suggested  that flavin reductases could play a key role 
in : iron metabolism (1, 2), activation of ribonucleotide reductase (3, 4) and 
reduction of methemoglobin (5, 6). There is also indirect evidence for their 
function in bioluminescence (7, 8) and oxygen reduction (9). Recently, flavin 
reductases have been found to be associated with oxygenases involved in the 
desulfurization process of fossil fuels (10) and antibiotic biosynthesis (11-13). 
 Up to now, two major classes of flavin reductases have been 
characterized. Class I enzymes do not contain any flavin prosthetic group and 
cannot be defined as flavoproteins (3, 14), whereas class II enzymes are 
canonical flavoproteins (15-17). These two classes also exhibit different 
enzymatic mechanisms for flavin reduction. Class I enzymes use a sequential 
mechanism (14), whereas class II use a Ping-Pong mechanism, as a consequence 
of having a redox cofactor bound to the polypeptide chain (17, 18). 
 The prototype for class I flavin reductases is an enzyme, named Fre 
1
, 
which was initially discovered in Escherichia coli as a component of a 
multienzymatic system involved in the activation of ribonucleotide reductase, a 
key enzyme in DNA biosynthesis (3, 4). Fre consists of a single polypeptide 
chain of 233 amino acids, with a molecular mass of 26,212 Da (19). It uses an 
electron donor which can be either NADPH or NADH and riboflavin (Rf) is the 
best substrate (3, 14). Steady-state kinetic studies have shown that Fre functions 
through an ordered mechanism, with NADPH binding first and riboflavin being 
the second substrate (14). Product order release has also been determined, with 
reduced flavin being the first product to be released and NADP
+
 the second (14). 
 Although Fre is not a flavoprotein, several lines of evidence suggested  
that Fre belongs to a large family of flavoenzymes of which spinach ferredoxin-
NADP
+
 reductase (FNR) is the structural prototype (20). In spite of very low 
global sequence similarity, Fre contains a sequence motif of four amino acids, 
R46PFS49, similar to the R93LYS96 region of spinach FNR. In the FNR family, 
these conserved residues are involved in the interaction between the protein and 
the flavin isoalloxazine ring (20). In spinach FNR, Ser96 has been proposed to 
make a hydrogen bond to the N(5) position of the FAD cofactor (20) and was 
found to be essential for activity (21). Site-directed mutagenesis experiments 
allowed us to demonstrate that Ser49 of Fre (corresponding to Ser96 of spinach 
FNR) is indeed involved in flavin binding, and that it is also essential for 
activity (22). These results were the first to support the structural relationship 
between Fre and the  members of the FNR family. 
 This was further confirmed by characterization of reaction intermediates 
which are formed during the catalytic cycle of Fre (23). For the flavoenzymes of 
the FNR family, rapid kinetic studies have demonstrated the occurrence of two 
distinct intermediates species during the catalytic cycle, identified as charge 
transfer complexes between pyridine nucleotide and the flavin cofactor (24-26). 
Similarly, in the case of Fre, the same two reaction intermediates of the catalytic 
cycle have been characterized (23). Together, these results now extend the 
structural similarity between Fre and the proteins of the FNR family to a 
functional level. 
 Substrate specificity studies on Fre using flavin analogs have shown that 
the isoalloxazine ring of the flavin is the only part of the molecule which is 
recognized by Fre (14). Such a weak interaction of Fre with the flavin provides a 
rational explanation why a protein related to a flavoprotein family can use a 
flavin as a substrate rather than as a cofactor (14).  
 In the present paper, using a variety of NAD(P) analogs, substrates or 
inhibitors, we have now studied the specificity of Fre for the reduced pyridine 
nucleotide, the other substrate. We have shown that Fre exhibits a unique mode 
of binding with the reduced pyridine nucleotide, which involves both the 
adenosine and the nicotinamide ring moiety of the molecule. However, when 
NADPH is used as electron donor, the presence of the 2’-phosphate  group of 
the molecule destabilized almost completely the interaction with the adenosine 
moiety. NADPH, as NMNH, binds to Fre with the nicotinamide ring almost 
exclusively. In addition, we have shown that Fre selectively transfers the pro-R 
hydrogen from the C-4 position of the nicotinamide group and is therefore 
classified as an A-side specific enzyme.   
 
EXPERIMENTAL PROCEDURES 
 
Biochemical and chemical reagents 
 Riboflavin (Rf), FAD, lumichrome, NAD(P)H analogs, lyophilized yeast 
alcohol dehydrogenase, lyophilized Thermoanaerobium brockii alcohol 
dehydrogenase, 2-propanol-d8 were obtained from Sigma. 
2
H2O (99.9+ atom % 
2
H) was from SDS. Others reagent-grade chemicals were obtained from either 
Sigma, Aldrich, or Bio-rad. 
Production of recombinant flavin reductase 
 Purification of the recombinant Escherichia coli Fre was carried out using 
a two-step protocol, phenyl-Sepharose and Superdex 75 as previously reported 
(14). The protein concentration was determined using the Bio-Rad Protein 
Assay reagent (27) and bovine serum albumin as a standard protein. 
Enzyme assays 
 Flavin reductase activity was determined from the decrease of the 
absorbance due to the oxidation of the reduced pyridine nucleotide in the 
presence of Rf or FAD, using a Varian Cary 1 Bio  spectrophotometer. 
Activities were measured at 25 °C in 50 mM Tris-Cl buffer pH 7.6. Assays were 
performed in 1 cm path length cuvette (final volume 1 ml). When high 
concentrations of NAD(P)H or NMNH were investigated, a 0.1 cm path length 
cuvette was used (final volume 0.3 ml). When lumichrome was present in the 
enzymatic assays, the cuvette contained in addition 87 mM Me2SO final 
concentration as reported in (14). The reaction was initiated by adding 0.2-15 µg 
of enzyme, depending of the reduced pyridine nucleotide used. Activities with 
NADPH and NADH were followed at 340 nm (=6.22 mM-1 cm-1), with NMNH 
at 338 nm (=5.72 mM-1 cm-1), with thio-NADH at 396 nm (=11.3 mM-1 cm-1), 
with 3-acetyl NADH at 364 nm (=5.6 mM-1 cm-1). Enzyme activities were 
determined from the linear part of the progress curve, with less than 10% of 
reduced pyridine nucleotide utilized over the time course of the reaction. 
Kinetic analysis 
 Reciprocal initial velocities were plotted against reciprocal substrate 
concentrations, and all plots were verified to be linear. Kinetic parameters (vm, 
Km, Kmapp) were determined from saturation curves, fitted with the equation 
vi=(vm[S])/(Km+[S]), using a Levenberg-Marquardt algorithm. Inhibition 
constants   (Ki) were determined using a replot of the Km apparent values (Kmapp) 
versus inhibitor concentration [I] and fitted with a straight line, assuming the 
equation for a competitive inhibitor : Kmapp=(Km/Ki)[I]+Km. When applicable, 
values are shown ± standard deviation. 
Substrate- product concentrations 
 NAD(P) analogs and flavin concentrations were determined 
spectroscopically using the following extinction coefficients : adenosine 
(260nm=14.9 mM
-1 
cm
-1
), AMP, ADP-ribose, ATP-ribose and 2’, 5’ ADP 
(259nm=15.4 mM
-1 
cm
-1
), ß-NAD(P)
+
 (259nm=17.8 mM
-1 
cm
-1
), ß-NMN
+
 
(266nm=4.6 mM
-1 
cm
-1
), nicotinamide (260nm=2.9 mM
-1 
cm
-1
), Rf (450nm=12.5 
mM
-1
 cm
-1
), FAD (450nm= 11.3 mM
-1
 cm
1
), lumichrome (nm= 6.0 mM
-1
 cm
-1
).   
Determination of the stereospecificity of the hydride transfer 
 [4R-
2
H] NADH and [4R-
2
H] NADPH were prepared from enzymatic 
reduction of NAD
+
 and NADP
+
 by 2-propanol-d8 as previously described (28, 
29). As a control NADH and NADPH were prepared by using non deuterated 
isopropanol. 
1
H-NMR spectra were recorded at 25°C on a Varian U
+
 500 
apparatus. The reaction mixture contained 3 mM [4R-
2
H] NADH or [4R-
2
H] 
NADPH in 1 ml of 50 mM of potassium phosphate buffer p
2
H 8, 25 µg of Fre, 
15 µM of Rf and was incubated at 25°C under aerobic conditions. The oxidation 
of [4R-
2
H] NAD(P)H was monitored spectrophotometrically at 340 nm. After 
total oxidation, 
1
H-NMR spectra of the samples were recorded. The 
stereospecificity of NAD(P)H was calculated from the ratio [peak area of C4-H 
( 8.74 ppm)] / [average peak area of C2-H ( 9.24 ppm) and C6-H ( 9.05 
ppm)]. 
RESULTS 
 
NAD(P)H analogs  as substrates 
 Scheme 1 shows the structures of the various NAD(P)H analogs studied. 
Table 1 shows the kinetic and thermodynamic parameters obtained with Fre in 
the presence of various NAD(P)H analogs as electron donors and riboflavin (Rf) 
as the electron acceptor. Kd values for the different NAD(P)H analogs were 
calculated from the Dalziel mathematical treatment of the initial velocities data 
(30), which proved to be well-adapted in the case of Fre (14, 22). For a 
sequential bireactant mechanism, where A and B are the first and second 
substrate of the reaction respectively, the initial reaction velocity, vi, can be 
expressed in a reciprocal form in terms of ’s parameters as suggested by 
Dalziel (30) :  
e/vi = o + A/[A] + B/[B] + AB/[A][B]  (1) 
where e is the enzyme concentration. The different  parameters in equation 1 
represent a combination of rate constants of each individual step of the 
sequential bireactant mechanism (30). A plot of the reciprocal of the 
concentration of A versus e/vi, at a constant concentration of B, will have a slope 
equal to A + AB/[B] and an Y-axis intercept equal to o + B/[B]. Secondary 
replots of the slopes and intercepts versus the reciprocal of the concentration of 
B will give the values of the different  parameters, as illustrated in Fig. 1. The  
parameters are related to the Km, kcat and Kd values of the reaction as follows :   
Km(A) = A/o; Km(B) = B/o; Kd(A) = AB/B; kcat  = 1/o 
 Km and kcat values for the different reduced pyridine nucleotides obtained 
by Dalziel treatment are checked to be identical to Km and kcat values determined 
from steady-state kinetic analysis of the reaction during experiments in which 
NAD(P)H analogs are varied in the presence of saturating concentration of Rf. 
In all cases, the Km value for Rf determined in the presence of different reduced 
pyridine nucleotides remained in the 1-10 M range (Table 1).  
 Unexpectedly, NMNH was found to be a very good substrate for the 
enzyme reduction of Rf. In Fig. 1, Fre activity was determined as a function of 
NMNH concentration at several levels of Rf. Double reciprocal plots show a 
series of intersecting lines to the left of the vertical axis, consistent with a 
sequential mechanism as observed in the case of NADPH, with Rf as the 
electron acceptor (14). The kcat value was significantly larger than that obtained 
with NADPH as the electron donor (Table 1). Km value for NMNH was found to 
be 3.5 and 14 times more elevated than the corresponding values for NADPH 
and NADH respectively and as a consequence the catalytic efficiency for 
NMNH, kcat/Km, was only reduced about 2.5 and 5-fold compared to that 
determined for NADPH and NADH respectively (Table 1). The Kd value for 
NMNH was 116±17 M, a value slightly larger than the Kd value from NADPH 
(54±9 M), determined under the same experimental conditions (Table 1). 
These data thus strongly suggested  that the adenosine phosphate part of the 
reduced pyridine nucleotide does not play a major role in the interaction with the 
Fre polypeptide chain and in the formation of the catalytic competent ternary 
complex with Rf (14, 23). 
 We have examined the inhibition pattern of NMN
+
 when NMNH was 
used as the electron donor and Rf as the electron acceptor. When NMNH was 
varied in the presence of a fixed non-saturating concentration of Rf, inhibition 
by NMN
+
 was found to be competitive with respect to NMNH (data not shown). 
A Ki value for NMN
+
 of 18 mM has been estimated (Table 2).  These results 
strongly suggest that the first product to be released is the reduced Rf, followed 
by NMN
+
, as with NADPH as electron donor (14).  
 Two NADH analogs, 3-acetyl NADH and thio-NADH, with limited 
modifications at the carboxamide group of the nicotinamide ring, were tested 
and also found to be substrates for the reaction catalyzed by Fre. However, they 
exhibited significantly lower kcat values compared to that of NADH (Table 1), 
which may reflect their higher redox potential values. Fre activity was 
determined as a function of 3-acetyl NADH concentration at several levels of Rf 
(data not shown). The double reciprocal plots of the initial velocities show a 
series of intersecting lines to the left of the vertical axis (data not shown), 
consistent with a sequential mechanism. Kd value determined for 3-acetyl 
NADH was found to be about 6 times larger than the corresponding value for 
NADPH, whereas its Km value was 13 and 52 times larger than the 
corresponding Km values for NADPH and NADH respectively (Table 1).  
 Km value for thio-NADH was found to be very low, 0.5 M (Table 1), 
suggesting an increased affinity of Fre for this compound. Because of the low 
Km and kcat values, Kd value for thio-NADH could not be accurately determined. 
 
Enzymatic mechanism with NADH as a substrate 
 Fig. 2 shows Fre activity determined as a function of NADH 
concentration at several levels of Rf. Surprisingly, double reciprocal plots of the 
initial velocity versus NADH concentration showed a series of parallel lines. 
When Fre activity was determined as a function of Rf at several levels of 
NADH, double reciprocal plots showed again a series of parallel lines (data not 
shown). When plotting the initial rate data in the form [S]/vi versus [S], where 
[S] is the concentration of the varied substrate, we obtained a series of lines that 
all intersect on the [S]/vi axis (data not shown). This confirms the parallel line 
pattern of the double reciprocal plots (31). Such a pattern would suggest a Ping-
Pong mechanism. In any case, data from Fig. 2 cannot be used to determine a Kd 
value for NADH with the Dalziel treatment.  
 That the reduction of Rf by NADH could involve a Ping-Pong mechanism 
was intriguing, considering that Fre does not contain a redox cofactor and that 
NADPH was clearly shown to function with a sequential mechanism. To further 
investigate the possibility of a Ping-Pong mechanism, we carried out a series of 
inhibition studies, with NADH as the electron donor. Table 2 shows that AMP 
was found to be a competitive inhibitor with respect to NADH (with a Ki value 
of 420±70 M) and non-competitive inhibition was observed with respect to Rf. 
Lumichrome is a strong competitive inhibitor with respect to Rf, with a Ki value 
of 60±9 nM, and an uncompetitive inhibitor with respect to NADH. These data 
do not support a Ping-Pong mechanism but are consistent with a sequential 
ordered mechanism with NADH binding first (32), as it has been previously 
reported for reduction of Rf by NADPH (14).  
 The parallel line pattern observed in Fig. 2 could then be explained by a 
dissociation constant value of NADH (AB/B) much smaller than its Michaelis 
constant (A/o), as suggested already by several authors (30, 31, 33). If this is 
the case, this makes AB difficult to estimate and equation 1 would become :e/vi 
= o + A/[A] + B/[B], assuming a parallel lines pattern for a sequential ordered 
mechanism. 
 The kinetic mechanism of product release for the Fre catalyzed reaction 
using NADH and Rf as substrates has been determined by studying  product 
inhibition. When NADH concentration was varied with a fixed, non saturating 
concentration of Rf, inhibition by NAD
+
 was found to be mixed-type with 
respect to NADH (Fig. 3A, Table 2). Furthermore, when Rf concentration was 
varied with a fixed, non saturating concentration of NADH, NAD
+
 was found to 
be mixed-type with respect to Rf (Fig. 3B, Table 2). These data strongly suggest 
that NAD
+
 is the first product to be released (33). 
 In conclusion, the enzyme works with NADH almost as with NADPH 
through a sequential ordered mechanism and the parallel line pattern observed in 
Fig. 2 can be explained by NADH having a Kd value much smaller than its Km 
value (8±1 M, Table 1). However, the reaction with NADH differs from that 
with NADPH in that NAD
+
 is the first reaction product to be released. 
NAD(P) analogs as dead-end inhibitors 
 The data reported in Table 1 suggested that the nicotinamide ribose 
phosphate part of the reduced pyridine nucleotide played a major role in binding 
to Fre. We have tested a variety of NAD(P) analogs, all lacking the nicotinamide 
ring (Scheme 1), as dead-end enzyme inhibitors (Table 3). All NAD(P) analogs 
tested in Table 3 were found to be competitive inhibitors with respect to 
NADPH. In the case of a sequential ordered mechanism, the inhibition constant 
Ki for a competitive inhibitor (I) with respect to the first substrate reflects the 
dissociation constant of the enzyme-inhibitor complex (EI) unless the second 
substrate can complex with EI to form an inactive ternary complex (34). In such 
a case, Ki must be smaller than the true dissociation constant of the enzyme-
inhibitor complex (34). In our case, an inhibition effect associated with an 
increased concentration of the second substrate, Rf, would be observed. This has 
been tested using AMP as the dead-end inhibitor. Fre activity was determined as 
a function of Rf concentration (varied in a 0.3-100 Km range) at a constant non 
saturating concentration of NADPH (100 M) with and without 2 mM AMP. 
Double reciprocal plots of the initial velocities versus Rf concentration gave no 
evidence of a substrate-inhibition pattern (data not shown). We thus conclude 
that, under these conditions, no ternary Fre-Rf-AMP complex was formed and 
as a consequence  the  Ki value reported in Table 3 can be interpreted as a true 
dissociation constant  for the AMP-enzyme complex. By extension, we consider 
that all Ki values reported in Table 3 are also true dissociation constants.  
 As shown in Table 3, Ki values for 2’, 5’ ADP and ATP-ribose are much 
larger than the Kd value for NADPH (3.7±1.0, 3.8±0.8 and 0.054±0.009 mM 
respectively). In addition, adenosine is a poor inhibitor with a Ki value of 9 mM. 
These data strengthen the hypothesis that binding of the NADPH molecule 
occurs mainly through the nicotinamide ring. On the other hand, Ki values for 
AMP and ADP-ribose, which are NAD analogs, are about 11 and 9 times 
smaller than the Ki values for 2’, 5’ ADP and ATP-ribose respectively. These 
observations strongly suggested  that the presence of the 2’-phosphate  group of 
the NADP analogs induces a destabilization of the interaction with the Fre 
polypeptide. This is also consistent with a smaller Kd value for NADH, which 
has been estimated to be lower than its Km value (8±1 M, see above), compared 
to that for NADPH (54±9 M). Furthermore, the finding that the Ki value for 
ADP-ribose is identical to that for AMP and that the Ki value for ATP-ribose is 
identical to that of 2’, 5’ ADP suggest that the phosphate ribose part of the ADP-
ribose and ATP-ribose molecules does not contribute significantly to the 
binding. Adenosine and nicotinamide were also found to be competitive 
inhibitors with respect to NADPH. However they are characterized by very high 
Ki values (9 and 20 mM respectively, Table 3). 
 
FAD reduction is specific for NADH 
 Table 4, shows the kinetic parameters for the enzymatic reduction of FAD 
by NADPH, NADH or NMNH. The kcat/Km values reported for the three reduced 
pyridine nucleotides clearly indicate that with FAD as the electron acceptor, Fre 
became highly NADH specific (Table 4). The kinetic parameters for the reaction 
(Table 4) can be compared to those for the reduction of Rf (Table 1) : when 
NADH was used as the electron donor, while kcat and Km values for the two 
flavins, FAD and Rf, were in the same range, the Km value for NADH was much 
larger in the case of FAD (301±40 M compared to 8±1 M in the case of Rf). 
With NADPH or NMNH as the electron donors this effect was much more 
pronounced, with Km values at around 15-20 mM (Table 4), as compared to Km 
values of 32±2 and 113±7 M for NADPH and NMNH respectively with Rf as 
electron acceptor (Table 1). kcat values, in the case of NADPH and NMNH, were 
smaller with FAD than with Rf as the electron acceptor and thus became 
comparable to the kcat value obtained with the NADH-FAD system (Table 4). On 
the whole, the increased specificity for NADH compared to NADPH and 
NMNH, in the case of FAD reduction, resulted mainly from a much larger effect 
on the Km values for NADPH and NMNH, whereas kcat values were only slightly 
affected. 
 
Stereospecificity of the hydride transfer 
 Both stereospecifically labeled [4R-
2
H] NADH and [4R-
2
H] NADPH 
were prepared by transferring deuterium from 2-propanol-d8 to NAD(P)
+
 with 
appropriate NAD(P)
+
-dependent alcohol dehydrogenases, which are specific for 
the transfer of the pro-R hydrogen of NAD(P)H. The isotopic purity of 
deuterated NAD(P)H was determined without purification by 
1
H-NMR 
spectrometry at 500 MHz. As shown in Fig. 4A, the two diastereotopic pro-R 
and pro-S hydrogen atoms at C-4 of the non-deuterated dihydronicotinamide 
ring of NADH were detected at 2.70 ppm and 2.58 ppm respectively. In the 
1
H-
NMR spectrum of the deuterated analog, the signal at 2.70 ppm has disappeared 
almost completely indicating that deuterium has been transferred specifically to 
the R-position (Fig. 4B). The enzymatic deuteration was less specific in the case 
of NADP
+
 and the isotopic purity of [4R-
2
H] NADPH was found to be 90% 
approximately (data not shown). 
 The stereoselectivity of the hydrogen transfer from [4R-
2
H] NADH to Rf 
catalyzed by Fre was determined from 
1
H-NMR analysis of the NAD
+
 product, 
as described in Materials and Methods. The almost complete disappearance of 
the peaks in the 2.7-2.9 ppm region, characteristic of NADH, indicated that 
oxidation to NAD
+
 was more than 95% completed (data not shown). Deuterium 
free NAD
+
, which can be obtained in a control experiment with NADH, has a 
characteristic C-4 proton doublet at 8.74 ppm, in the aromatic region of the 
1
H 
NMR spectrum (Fig. 5A). The presence of this doublet, also present  in the 
product of [4R-
2
H] NADH oxidation, unambiguously shows that Fre preferably 
transfers the deuterium from the pro-R position resulting in the formation of 
deuterium free NAD
+
, as the major product (Fig. 5B). Comparison of the 
intensities of the aromatic signals however showed that a minor amount (less 
than 10%) of deuterated NAD
+
 was also formed. The latter could be assigned to 
the non-enzymatic reduction of free flavin by NADH, which was previously 
shown to be effective at the high concentrations of electron donor used in this 
study (9). Comparable results have been obtained when the stereoselectivity of 
the hydrogen transfer from [4R-
2
H] NADPH to Rf catalyzed by Fre was 
determined under the same experimental conditions (data not shown).  
 These results show that the hydride transfer is pro-R stereospecific during 
reduction of Rf by NAD(P)H catalyzed by Fre. 
 
DISCUSSION 
 
 The NAD(P)H:flavin oxidoreductase from E.coli, named Fre, is the 
prototype for the class of cofactor-free flavin reductases. The mechanism of the 
reaction has been partially elucidated previously with the demonstration that the 
flavin reductase provides a site which accommodates both reduced pyridine 
nucleotides and flavins, in which the hydride transfer takes place (14, 23). 
 In a previous paper, we identified the parameters governing the interaction 
of the flavin substrate with the enzyme polypeptide chain (14). The interesting 
conclusion was that binding of the flavin involved the isoalloxazine ring almost 
exclusively, with little contribution from the sugar chain. In the present work, 
we have studied the interaction of the pyridine nucleotide with the enzyme and 
show that Fre has also some unique properties with regard to that interaction. 
 Although Fre can operate with both NADH and NADPH when using Rf 
as the electron acceptor, we have found that the presence of the 2'-phosphate 
group had a destabilizing effect on the binding of the pyridine nucleotide to Fre. 
This is clear from the following observations : i) Kd value for NADH has been 
estimated to be smaller than its Km value (8±1 M), reflecting a better affinity of 
the protein for NADH than for NADPH (Kd value of 54±9 M); ii) Kd values, 
for AMP and ADP-ribose were 10 times smaller than the Kd values for 2', 5' 
ADP and ATP-ribose. 
 On the other hand, our results strongly suggested that the adenosine-ribose 
moiety of the NAD(P)H molecules is not important for the interaction between 
the pyridine nucleotide molecule and the protein. As a matter of fact, the Kd 
values for AMP or ADP-ribose moiety of the NADH molecule and for 2’, 5’ 
ADP or ATP-ribose moiety of the NADPH molecule are much higher than the 
Kd values estimated and determined for the corresponding substrate, NADH and 
NADPH. That the nicotinamide ring itself could have a marked contribution to 
the binding of the pyridine nucleotide to Fre was further supported by the 
following data.  
 First, the affinity of the pyridine nucleotide is strongly affected by 
modification of the  carboxamide group of the nicotinamide ring, as illustrated 
by the larger differences between Km and Kd values determined for 3-acetyl 
NADH, thio-NADH and the values estimated for NADH (Table 1). Second, 
NMNH, which lacks the adenosine part of the NAD(P)H molecule, was found to 
be a very good substrate for Fre and exhibited a Kd value only 2 times higher 
than that of NADPH (Table 1). Taking into account that the same Kd values were 
obtained for AMP and ADP-ribose on one side and for 2', 5' ADP and ATP-
ribose on the other side, one could conclude that binding of NMNH occurs 
mainly by its nicotinamide ring with no marked contribution of its phosphate 
ribose moiety. 
 Taken together, all these results clearly confirmed the presence of a 
specific recognition site for the nicotinamide ring on the Fre polypeptide chain 
with significant contribution to the binding of the reduced pyridine nucleotide. 
 As mentioned above, the Kd values for NMNH and NADPH were found 
to be comparable. This suggests that the negative effect of the NADPH 2'-
phosphate  group on the protein-substrate interaction cancels almost completely 
the binding effect of the adenosine part of the molecule. These observations 
suggest a similar mode of binding of NADPH and NMNH, with the main 
interaction occurring with the nicotinamide ring. NADH, in contrast, binds to 
Fre through interactions involving both the nicotinamide ring and the adenosine 
part of the molecule.  
 The difference between NADPH, NMNH, on one side, and NADH on the 
other side, with regard to binding to Fre is also reflected in the kinetic 
parameters determined in the presence of FAD as the electron acceptor (Table 
4). The data show that FAD induces a dramatic increase of the Km values for 
NADPH and NMNH, whereas Km value for NADH is much less affected. Even 
though the basis of this difference is difficult to identify, these data further 
support the notion of a comparable binding mode of NADPH and NMNH. 
 In addition, it seems that the order of release of the products from this 
enzyme can be different from one pyridine nucleotide to another. With NMNH 
and NADPH as electron donors, the enzyme mechanism displays the same order 
of product release, with the reduced flavin released first followed by NMN
+
 or 
NADP
+
. This is in contrast with NADH, for which the order of product release 
is reversed. However, the present data gives no clear indication which might 
explain these differences. 
 We have determined that the enzymatic hydride transfer is stereospecific 
for the C-4 pro-R hydrogen atom of the nicotinamide ring of the NAD(P)H and 
then that Fre can be classified as an A-side NAD(P)H dependent oxidoreductase. 
This provides further support for our suggestion that Fre is structurally and 
mechanistically related to the FNR family (22, 23). As a matter of fact, members 
of the FNR family are A-side enzymes, in contrast to members of an other 
flavoprotein family, the disulfide reductase family, which are B-side enzymes 
(35).  
 In the case of the flavoproteins of the FNR family, the binding mode of 
the pyridine nucleotide with the protein seems to be completely different from 
what we have found in the case of Fre. In fact, in the case of spinach FNR (36) 
and nitrate reductase (37), binding and inhibition studies using NAD(P) analogs, 
suggested  that  binding of the pyridine nucleotide to the proteins, involved the 
adenosine part of the molecule exclusively with no contribution of the 
nicotinamide ring. This has been partly confirmed by the structure of the spinach 
FNR complexed with NAD(P) analogs,  which showed ordered binding of only 
the adenosine phosphate moiety of the pyridine nucleotide molecule (20). The 
crystal structure of the PDR-NADH complex, where the entire pyridine 
nucleotide molecule is seen, has revealed that the nicotinamide ring is not 
correctly positioned for hydride transfer with the flavin cofactor (38). A 
conformational change was postulated in order to allow direct contact of the 
nicotinamide ring and the flavin (38).  This is supported by rapid kinetic studies 
on PDR which suggested a two-step mechanism for NADH binding (25, 26). 
 In the case of alcohol dehydrogenase from horse liver, a two-step binding 
mode of pyridine nucleotide has also been proposed. The first binding step 
would consist of docking of the adenosine part of the pyridine nucleotide and 
the second of conformational isomerization for the binding of the nicotinamide 
part (39). The fact that the nicotinamide ring is apparently not directly 
recognized by the active site of these NAD(P) dependent dehydrogenase is in 
keeping with the fact that NMN(H) has never been reported, to our knowledge, 
to be an efficient substrate in an enzyme NAD(P)-dependent reaction. 
 Recognition of the pyridine nucleotide by Fre, by both the adenosine and 
nicotinamide moiety (for the case of NADH) or almost exclusively by the 
nicotinamide moiety (for the case of NADPH) appears to be unusual. It could 
thus represent a new type of pyridine nucleotide binding mechanism, which has 
never been described previously. That this NAD(P)H binding mechanism is 
different from what it was suggested for the flavoproteins of the FNR family, 
may contribute to make Fre a flavin reductase rather than a flavoprotein, in spite 
of the structural and functional homologies between these two classes of protein 
(22, 23).  
 Finally, this work and a previous one (14) establishes that Fre exhibits a 
very unique mode of binding for both substrates which sets it apart from other 
NAD(P)H- and flavin-dependent enzymes. It uses a remarkable symmetrical 
strategy for recognition of the NAD(P)H and the flavin. In both cases, it is 
mainly the redox part of the substrate molecules, the nicotinamide ring and the 
isoalloxazine ring, which are recognized by the polypeptide chain.  
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FOOTNOTES 
 
1
 The abbreviations used are : Fre, NAD(P)H : flavin oxidoreductase; FNR, 
ferredoxin-NADP
+
 reductase; PDR, phthalate dioxygenase reductase; Rf, 
riboflavin; AMP, adenosine 5’-monophosphate; 2’, 5’ ADP, 2’-
phosphoadenosine  5’-phosphate; ADP-Ribose, adenosine 5’-
diphosphoribose; ATP-ribose, 2’-phosphoadenosine 5’-diphosphoribose; 
NMNH, -nicotinamide mononucleotide reduced form; 3-acetyl NADH, 3-
acetylpyridine adenine dinucleotide reduced form; thio-NADH, 
thionicotinamide adenine dinucleotide reduced form; vi , initial velocity; vm , 
maximal velocity; Kmapp , apparent Michaelis constant; e, enzyme 
concentration; o, A, B, AB, kinetic parameters defined by Dalziel (30); nd, 
not determined. 
 
 
 
FIGURE LEGENDS 
 
Scheme 1. Structure of the different pyridine nucleotide analogs.  
 
Figure 1. A, flavin reductase initial velocity as a function of NMNH 
concentration in the presence of 1.00 ( ), 1.25 ( ), 2.00 ( ) or 3.00 M ( ) 
Rf. The flavin reductase concentration, e, used in the assay was 0.0192 M. The 
results are presented as double reciprocal plots with straight line determined by a 
linear regression program. B, secondary plot of the slopes from A against 1/[Rf] 
and fitted with a straight line, corresponding to the equation : y = AB x + A. C, 
secondary plot of the intercepts from A against 1/[Rf] and fitted with a straight 
line, corresponding to the equation : y = B x + 0. 
 
Figure 2. Double reciprocal plots of the flavin reductase initial velocity as a 
function of NADH concentration in the presence of 0.25 ( ), 0.50 ( ), 1.00 
( ) or 20.00 M ( ) Rf.  
 
Figure 3. A, NAD
+
 as a mixed-type inhibitor for NADH. The enzyme initial 
velocity was assayed as a function of NADH concentrations using 1 M Rf, in 
the absence  ( ) or in the presence of 0.47 ( ), 0.95 ( ) or 1.43 ( ) mM 
NAD
+
. B, NAD
+
 as a mixed-type inhibitor for Rf. The enzyme initial velocity 
was assayed as a function of Rf concentrations using 10 M NADH, in the 
absence  ( ) or in the presence of 3 ( ), 4 ( ) or 5 ( ) mM NAD
+
. 
 
Figure 4. 
1
H-NMR spectra (500 MHz) of NADH (A) and [4R-
2
H] NADH (B) 
obtained by enzymatic reduction. 
 
Figure 5. Aromatic region of the 
1
H-NMR spectra (500 MHz) of NAD
+
 obtained 
from the Fre-catalyzed reduced pyridine nucleotide oxidation in the presence of 
Rf. A : NAD
+
 obtained from NADH enzymatic oxidation. B : NAD
+
 obtained 
from [4R-
2
H] NADH enzymatic oxidation. 
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